Applications Now Open – Advancing Treatment Of Repeated Mild Traumatic Brain Injury

Advertisement

BEGIN ARTICLE PREVIEW:

CHARLESTON, S.C., Sept. 16, 2020 /PRNewswire/ — In partnership with BrightFocus Foundation, the Medical Technology Enterprise Consortium (MTEC) today announced a request for proposals for research that will enable the advancement of candidate drugs for the treatment of repeated mild traumatic brain injury (mTBI). “We invite scientists and researchers from all over the world to respond to this critical need.  Despite numerous clinical trials on potential therapies, there is no FDA approved drug therapy for the treatment of TBI,” said Lauren Palestrini, PhD, Director of Research Programs at MTEC. BrightFocus Foundation and MTEC have come together to address a critical need in TBI research.  Repeated mTBIs – which are common in contact sports and military settings – have been indicated as a risk factor in developing various neurodegenerative diseases.  This research has the potential to impact service members on the front line, as well as our mothers, fathers, sons and daughters.MTEC and BrightFocus are jointly funding up to $500,000, with the goal of catapulting drugs for the treatment of repeated mTBI toward human clinical trials. Relevance to both the military and Alzheimer’s disease (AD) is an important aspect of this Request for Project Proposals (RPP).About MTECThe Medical Technology Enterprise Consortium (MTEC) is …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE